Literature DB >> 16389400

Fluoroquinolone drug class update.

A Bichsel1, C W James, C Gurk-Turner.   

Abstract

Entities:  

Year:  2000        PMID： 16389400      PMCID： PMC1317058          DOI： 10.1080/08998280.2000.11927690

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium.

Authors:  S Lober; S Ziege; M Rau; G Schreiber; A Mignot; P Koeppe; H Lode
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis.

Authors:  R Wilson; R Kubin; I Ballin; K M Deppermann; H P Bassaris; P Leophonte; A J Schreurs; A Torres; B Sommerauer
Journal:  J Antimicrob Chemother       Date:  1999-10       Impact factor: 5.790

3.  Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans.

Authors:  M Nakashima; T Uematsu; K Kosuge; H Kusajima; T Ooie; Y Masuda; R Ishida; H Uchida
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

Review 4.  Moxifloxacin.

Authors:  J A Balfour; L R Wiseman
Journal:  Drugs       Date:  1999-03       Impact factor: 9.546

5.  Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group.

Authors:  T Burke; C Villanueva; H Mariano; W Huck; D Orchard; D Haverstock; A Heyd; D Church
Journal:  Clin Ther       Date:  1999-10       Impact factor: 3.393
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.